David Fractor serves as Executive at ImmunoCellular Therapeutics, Ltd., where they oversee executive responsibilities. Since joining the company, David Fractor has executed 3 insider transactions totaling $10.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 11, 2016 involved receiving (via award) 35,000 shares valued at $0.
David Fractor currently holds 70,000 shares of ImmunoCellular Therapeutics, Ltd. (IMUC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Fractor has been a net buyer of IMUC stock. They have purchased $10.0K and sold $0 worth of shares.
David Fractor's most recent insider trade was on Mar 11, 2016, when they sold 35,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 18, 2015 | IMUC | $10.0K | Purchase | 16,667 | $0.60 | Discretionary |